These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 34326372)

  • 21. LncRNA WT1-AS Inhibits Triple-Negative Breast Cancer Cell Migration and Invasion by Downregulating Transforming Growth Factor β1.
    Wang J; Xi C; Yang X; Lu X; Yu K; Zhang Y; Gao R
    Cancer Biother Radiopharm; 2019 Dec; 34(10):671-675. PubMed ID: 31621381
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification of Hub Genes and Upstream Regulatory Factors Based on Cell Adhesion in Triple-negative Breast Cancer by Integrated Bioinformatical Analysis.
    Han YH; Wang Y; Lee SJ; Mao YY; Jiang P; Sun HN; Jin MH; Kwon T
    Anticancer Res; 2023 Jul; 43(7):2951-2964. PubMed ID: 37351977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA OTUD6B-AS1 promotes paclitaxel resistance in triple negative breast cancer by regulation of miR-26a-5p/MTDH pathway-mediated autophagy and genomic instability.
    Li PP; Li RG; Huang YQ; Lu JP; Zhang WJ; Wang ZY
    Aging (Albany NY); 2021 Nov; 13(21):24171-24191. PubMed ID: 34740994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Potential Long Non-Coding RNA Candidates that Contribute to Triple-Negative Breast Cancer in Humans through Computational Approach.
    Rahman MM; Hossain MT; Reza MS; Peng Y; Feng S; Wei Y
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation.
    Drago-Ferrante R; Pentimalli F; Carlisi D; De Blasio A; Saliba C; Baldacchino S; Degaetano J; Debono J; Caruana-Dingli G; Grech G; Scerri C; Tesoriere G; Giordano A; Vento R; Di Fiore R
    Oncotarget; 2017 Apr; 8(17):28939-28958. PubMed ID: 28423652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
    Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y
    Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. lncRNA GAS5-promoted apoptosis in triple-negative breast cancer by targeting miR-378a-5p/SUFU signaling.
    Zheng S; Li M; Miao K; Xu H
    J Cell Biochem; 2020 Mar; 121(3):2225-2235. PubMed ID: 31692053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA SLC16A1-AS1 regulates the miR-182/PDCD4 axis and inhibits the triple-negative breast cancer cell cycle.
    Jiang B; Liu Q; Gai J; Guan J; Li Q
    Immunopharmacol Immunotoxicol; 2022 Aug; 44(4):534-540. PubMed ID: 35316129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating NCALD.
    Luo D; Liang Y; Wang Y; Ye F; Jin Y; Li Y; Han D; Wang Z; Chen B; Zhao W; Wang L; Chen X; Jiang L; Yang Q
    Breast Cancer Res; 2023 Sep; 25(1):109. PubMed ID: 37770991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Positive Feedback Loop Between TGFβ and Androgen Receptor Supports Triple-negative Breast Cancer Anoikis Resistance.
    Rosas E; Roberts JT; O'Neill KI; Christenson JL; Williams MM; Hanamura T; Spoelstra NS; Vahrenkamp JM; Gertz J; Richer JK
    Endocrinology; 2021 Feb; 162(2):. PubMed ID: 33294922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. lncRNA ACTA2-AS1 predicts malignancy and poor prognosis of triple-negative breast cancer and regulates tumor progression via modulating miR-532-5p.
    Peng Y; Huang X; Wang H
    BMC Mol Cell Biol; 2022 Jul; 23(1):34. PubMed ID: 35896973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA ANRIL promotes carcinogenesis via sponging miR-199a in triple-negative breast cancer.
    Xu ST; Xu JH; Zheng ZR; Zhao QQ; Zeng XS; Cheng SX; Liang YH; Hu QF
    Biomed Pharmacother; 2017 Dec; 96():14-21. PubMed ID: 28961506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MYBL2-induced PITPNA-AS1 upregulates SIK2 to exert oncogenic function in triple-negative breast cancer through miR-520d-5p and DDX54.
    Liu B; Yao P; Xiao F; Guo J; Wu L; Yang Y
    J Transl Med; 2021 Aug; 19(1):333. PubMed ID: 34353336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA NEF is downregulated in triple negative breast cancer and correlated with poor prognosis.
    Song X; Liu Z; Yu Z
    Acta Biochim Biophys Sin (Shanghai); 2019 Apr; 51(4):386-392. PubMed ID: 30839051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of dysregulated miRNAs in triple negative breast cancer: A meta-analysis approach.
    Naorem LD; Muthaiyan M; Venkatesan A
    J Cell Physiol; 2019 Jul; 234(7):11768-11779. PubMed ID: 30488443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentiation of cancerous progression by LISCH7 via direct stimulation of TGFB1 transcription in triple-negative breast cancer.
    Tang X; Zhou Y; Liu Y; Zhang W; Liu C; Yan C
    J Cell Biochem; 2020 Nov; 121(11):4642-4653. PubMed ID: 32048750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. lncRNA SEMA3B-AS1 Inhibits miR-513c-5p to Regulate the Progression of Triple-negative Breast Cancer.
    Yu H; Wu Y; Huang J; Li S
    Anticancer Res; 2023 Dec; 43(12):5475-5484. PubMed ID: 38030196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The regulatory effect of 6-TG on lncRNA-miRNA-mRNA ceRNA network in triple-negative breast cancer cell line.
    Zhang D; An X; Yu H; Li Z
    Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33470407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA MCM3AP-AS1 Downregulates LncRNA MEG3 in Triple Negative Breast Cancer to Inhibit the Proliferation of Cancer Cells.
    Ren G; Han G; Song Z; Zang A; Liu B; Hu L; Jia L; Hong D; Yang L; Qie S
    Crit Rev Eukaryot Gene Expr; 2021; 31(4):81-87. PubMed ID: 34587438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD.
    Wu D; Jia H; Zhang Z; Li S
    Bioorg Chem; 2021 Apr; 109():104722. PubMed ID: 33618253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.